HAMMAD MOHSIN: Open Payments
NPI 1205167624 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 48 payments from 14 companies in 2025. Trend: 2023 $981 · 2024 $3,940 · 2025 $1,523
Food & beverage: $1,523
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $320 |
| Alkermes, Inc. | 7 | $267 |
| ABBVIE INC. | 6 | $253 |
| Otsuka America Pharmaceutical, Inc. | 8 | $190 |
| Indivior Inc. | 3 | $151 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Corium, LLC | 2 | $56 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $34 |
Products named: CAPLYTA, VRAYLAR, REXULTI, SUBLOCADE, ARISTADA, LYBALVI, UZEDY, Azstarys.
Industry payments across NY — which companies pay providers there.
